Ignite Creation Date:
2025-12-25 @ 3:28 AM
Ignite Modification Date:
2026-03-09 @ 6:16 PM
Study NCT ID:
NCT05215405
Status:
NO_LONGER_AVAILABLE
Last Update Posted:
2025-02-03
First Post:
2022-01-17
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Expanded Access Program of Venetoclax and Navitoclax for Pediatric Patients with Relapsed or Refractory ALL or LL
Sponsor:
Kathleen Ludwig
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
STU-2021-1222
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None